The National Society of Genetic Counselors supports regulation of DNA testing for health-related conditions and hereditary diseases for clinical use. Any decision to regulate genetic testing should be patient-focused and should carefully consider the potential risk of stifling technological advancements that are critical to the fields of genetics, genomics, and precision medicine.
Regulation should not impede patient access to high-quality clinically useful information. Goals should include protecting patients from undue harm by developing clinical utility and analytical validity programs; ensuring that practitioners correctly interpret results; and creating transparency in the use, or intended application, of a genetic test. (Adopted 2017; replaces 2010 version)
Back to Position Statements